Notes from the
frontlines
of patient access
Recent writing from the team
Leveraging AI To Return Clinician Time to Patient-facing Care
The amount of administrative work in healthcare has crept higher and higher over time. In the age of AI, this presents an opportunity to utilize technology to work for the care team and reclaim that time for patient-facing care.
Medication Access Done Right
How Cinnamon helps health systems serve more patients sustainably
Silence as a Feature: Why Cinnamon’s Healthcare AI Doesn't Answer Every Question
Learn how Cinnamon utilizes the strengths of AI and avoids its weaknesses, while maintaining a human-in-the-loop workflow.
The Uncompensated Cost of Manual Prior Authorization Workflows
Fragmented, manual prior authorization submissions increase administrative spend. Approval delays can inflate total cost of care when patients are unable to start therapy as expected, if at all. See how costs related to PA can be reduced with a streamlined workflow.
A Guide to Your Pharma Field Team: Resources for Patient Access and Support
A description of pharma field team roles, titles, and how they can best support the care team.
Upcoming Prior Authorization Reforms: What Will Change, What Won’t, and What's Left Out
A look at the timeline of recently implemented and anticipated CMS rules relating to interoperability and prior authorization as of July 2026.
Why Pharma Needs a Unified Medication Access Ecosystem
Meet Cinnamon and the new, unified model for medication access: automating prior authorization and closing affordability gaps.
Medication Access Breakdowns: Why They Happen and and Cinnamon’s Solution
Access to medication can break down in a lot of ways - prior authorization requirements, affordability gaps, lack of transparency, and more. Take a deeper look into these barriers and how a single, connected solution can provide a fix.
MGMA’s 2026 Regulatory Burden Report: Key Findings and the Future of Medication Access
MGMA’s 2026 Report reveals a growing need for medication access infrastructure. Read more about what policy reforms can fix and can't fix and recommended practices for designing medication access at scale.
Avenues to Affordability
Financial Support Options for Costly Medications